Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2399700 | 1.00 | RAB9A (0.43) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL2401918 | 0.90 | C5AR1 (0.38) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL2401914 | 0.90 | C5AR1 (0.38) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL4620452 | 0.88 | ALDH1A1 (0.39) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL13609928 | 0.87 | ALDH1A1 (0.42) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL805450 | 0.84 | ALDH1A1 (0.48) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL13609923 | 0.84 | ALDH1A1 (0.48) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL22453309 | 0.81 | ALDH1A1 (0.43) | RAB9AALDH1A1SMN1; SMN2KMT2AKDM4E | |
| SCHEMBL24293675 | 0.79 | ALDH1A1 (0.41) | RAB9AALDH1A1SMN1; SMN2KMT2ALMNA | |
| SCHEMBL3201661 | 0.77 | ALDH1A1 (0.45) | RAB9AALDH1A1SMN1; SMN2KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8025867-B2 | Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds | L'OREAL (FR) | 2011-09-27 | — | — | US | disclosed |
| US-20080305058-A1 | Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds | L'OREAL (FR) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305058-A1 | Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds | DDT, DSG1, DSC1 | RAB9A 1085/4885ALDH1A1 809/4885SMN1; SMN2 3755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.